HOME >> BIOLOGY >> NEWS
Novel sugar-to-hydrogen technology promises transportation fuel independence

Blacksburg, Va., May 23, 2007 -- The hydrogen economy is not a futuristic concept. The U.S. Department of Energy's 2006 Advance Energy Initiative calls for competitive ethanol from plant sources by 2012 and a good selection of hydrogen-powered fuel cell vehicles by 2020.

Researchers at Virginia Tech, Oak Ridge National Laboratory (ORNL), and the University of Georgia propose using polysaccharides, or sugary carbohydrates, from biomass to directly produce low-cost hydrogen for the new hydrogen economy.

According to the DOE, advances are needed in four areas to make hydrogen fuel an economical reality for transportation production, storage, distribution, and fuel cells. Most industrial hydrogen currently comes from natural gas, which has become expensive. Storing and moving the gas, whatever its source, is costly and cumbersome, and even dangerous. And there is little infrastructure for refueling a vehicle.

"We need a simple way to store and carry hydrogen energy and a simple process to produce hydrogen, said Y.-H. Percival Zhang, assistant professor of biological systems engineering at Virginia Tech.

Using synthetic biology approaches, Zhang and colleagues Barbara R. Evans and Jonathan R. Mielenz of ORNL and Robert C. Hopkins and Michael W.W. Adams of the University of Georgia are using a combination of 13 enzymes never found together in nature to completely convert polysaccharides (C6H10O5) and water into hydrogen when and where that form of energy is needed. This "synthetic enzymatic pathway"research appears in the May 23 issue of PLoS ONE, the online, open-access journal from the Public Library of Science (www.plosone.org).

Polysaccharides like starch and cellulose are used by plants for energy storage and building blocks and are very stable until exposed to enzymes. Just add enzymes to a mixture of starch and water and "the enzymes use the energy in the starch to break up water into only carbon dioxide and
'"/>

Contact: Susan Trulove
STrulove@vt.edu
540-231-5646
Virginia Tech
22-May-2007


Page: 1 2 3 4

Related biology news :

1. Novel system developed to turn data into real-time, interactive 3-D images
2. Novel strategies for healthy aging
3. Novel salamander robot crawls its way up the evolutionary ladder
4. Novel test identifies lymphoma patients likely to respond to new therapy
5. Novel laboratory technique nudges genes into activity
6. Novel approaches to tackling obesity, cancer and MRSA
7. Novel approach to cancer drug given major boost
8. Novel regulation of the common tumor suppressor PTEN
9. Novel EGFR ectodomain mutations in glioblastoma
10. Novel regulatory mechanism identified for key tumor suppressor p53
11. Novel experiment documents evolution of genome in near-real time

Post Your Comments:
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
(Date:5/21/2013)... Water Center today awarded 12 research grants, totaling ... protection efforts. , The two-year grants of up ... to track the remediation of harmful algae blooms; ... weedy plant invasions; study chromosomal damage in tree ... activities. , The grants were awarded to multidisciplinary ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4
(Date:5/21/2013)... , May 21, 2013 ... Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services ... Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, ... in 2011 and is expected to grow at a ... an estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013  MacroGenics, Inc. today announced that ... (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), in ... oncoprotein," will be presented at the 2013 Annual ... during the Developmental Therapeutics - Immunotherapy Oral Abstract ... 4:30 PM.  The presentation will describe the results ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... May 21, 2013 Possible mold re-infestation in ... according to a report from eagletribune.com posted May 14, 2013, ... case the result is positive, My Cleaning Products offered a ... chemical ingredients. , It was said in the Eagle Tribune ... in the campus sparked after a first-grade classroom was closed ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: